Dassault Systèmes has invested in Click Therapeutics to enhance the patient experience in healthcare through integrated digital therapeutic solutions.

Information on the Target

Click Therapeutics is at the forefront of the prescription digital therapeutics sector, setting benchmarks for software-enhanced drug therapies. The company specializes in developing evidence-based digital therapies that are designed to treat serious medical conditions, supporting pharmaceutical companies in enhancing the patient's treatment journey.

By leveraging digital advancements and vast data analytics, Click Therapeutics aims to bridge the gap between traditional medical treatments and innovative digital solutions. This position allows them to influence patient care positively and streamline the integration of technology within healthcare practices.

Industry Overview in the Target’s Specific Country

The digital therapeutics industry has experienced significant growth in recent years, particularly in the United States. As healthcare increasingly shifts towards personalized medicine,

View Source

Similar Deals

Walgreens Boots Alliance, Inc. Cencora, Inc.

2025

Other Corporate Healthcare Facilities & Services (NEC) United States of America
Danaher Corporation Innovaccer Inc.

2025

Other Corporate Healthcare Facilities & Services (NEC) United States of America
NAMSA WuXi AppTec's U.S. medical device testing operations

2025

Other Corporate Pharmaceuticals (NEC) United States of America
Gentex Corporation eSight

2024

Other Corporate Advanced Medical Equipment & Technology (NEC) United States of America
SAIGroup Get Well

2024

Other Corporate Telemedicine Services United States of America
Edwards Lifesciences Innovalve Bio Medical Ltd.

2024

Other Corporate Medical Devices & Implants United States of America

Dassault Systèmes

invested in

Click Therapeutics

in 2025

in a Other Corporate deal

Deal Parameters
Industry
Country
Seller type

Sign Up to Dealert